{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:12:28Z","timestamp":1780405948873,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22201267"],"award-info":[{"award-number":["22201267"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bmc.2025.118396","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:08:59Z","timestamp":1758132539000},"page":"118396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of hydroxamate derivatives as potent anti-gastric cancer agents via inducing oxidative stress and DNA damage"],"prefix":"10.1016","volume":"131","author":[{"given":"Yi-Chao","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao-Jie","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Li","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2025.118396_bb0005","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/cac2.12197","article-title":"Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020","volume":"41","author":"Qiu","year":"2021","journal-title":"Cancer Commun (Lond)"},{"key":"10.1016\/j.bmc.2025.118396_bb0010","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s10120-024-01494-6","article-title":"Global burden of young-onset gastric cancer: a systematic trend analysis of the global burden of disease study 2019","volume":"27","author":"Li","year":"2024","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.bmc.2025.118396_bb0015","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.bmc.2025.118396_bb0020","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bmc.2025.118396_bb0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-020-01185-7","article-title":"Noncoding RNAs in gastric cancer: implications for drug resistance","volume":"19","author":"Wei","year":"2020","journal-title":"Mol Cancer"},{"key":"10.1016\/j.bmc.2025.118396_bb0030","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2013.02.015","article-title":"Free radicals, antioxidant defense systems, and schizophrenia","volume":"46","author":"Wu","year":"2013","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bmc.2025.118396_bb0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.ejmech.2015.04.040","article-title":"The role of antioxidants in the chemistry of oxidative stress: a review","volume":"97","author":"Pisoschi","year":"2015","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1101\/gad.1756509","article-title":"Tumor suppressors and cell metabolism: a recipe for cancer growth","volume":"23","author":"Jones","year":"2009","journal-title":"Genes Dev"},{"key":"10.1016\/j.bmc.2025.118396_bb0045","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrc3803","article-title":"Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles\u2019 heel?","volume":"14","author":"Sabharwal","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2025.118396_bb0050","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semcancer.2018.08.010","article-title":"Oxidative stress-modulating drugs have preferential anticancer effects - involving the regulation of apoptosis, DNA damage, endoplasmic reticulum stress, autophagy, metabolism, and migration","volume":"58","author":"Tang","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.bmc.2025.118396_bb0055","doi-asserted-by":"crossref","first-page":"5381692","DOI":"10.1155\/2019\/5381692","article-title":"Understanding of ROS-inducing strategy in anticancer therapy","volume":"2019","author":"Kim","year":"2019","journal-title":"Oxidative Med Cell Longev"},{"key":"10.1016\/j.bmc.2025.118396_bb0060","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2009.04.043","article-title":"Peroxiredoxins, a novel target in cancer radiotherapy","volume":"286","author":"Zhang","year":"2009","journal-title":"Cancer Lett"},{"key":"10.1016\/j.bmc.2025.118396_bb0065","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.trecan.2020.04.009","article-title":"Mitochondrial stress response and Cancer","volume":"6","author":"O\u2019Malley","year":"2020","journal-title":"Trends Cancer"},{"key":"10.1016\/j.bmc.2025.118396_bb0070","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.7150\/ijbs.59404","article-title":"Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells","volume":"17","author":"Wei","year":"2021","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.bmc.2025.118396_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","article-title":"The role of cellular reactive oxygen species in cancer chemotherapy","volume":"37","author":"Yang","year":"2018","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.bmc.2025.118396_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2018.101084","article-title":"ROS and the DNA damage response in cancer","volume":"25","author":"Srinivas","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.bmc.2025.118396_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/s12013-025-01845-9","article-title":"Oxidative stress in DNA damage and neurodegenerative diseases: unveiling the mechanisms and therapeutic opportunities","author":"Rahman","year":"2025","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.bmc.2025.118396_bb0090","doi-asserted-by":"crossref","first-page":"8827","DOI":"10.1021\/acs.jmedchem.0c01676","article-title":"Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic strategy","volume":"64","author":"Adhikari","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1080\/13543776.2024.2391289","article-title":"A patent review of histone deacetylase 8 (HDAC8) inhibitors (2013-present)","volume":"34","author":"Banerjee","year":"2024","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bmc.2025.118396_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108700","article-title":"Hydroxamic acid hybrids as histone deacetylase inhibitors for cancer therapy: an update (2022 to date)","volume":"163","author":"Cheng","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112679","article-title":"Hydroxamic acid hybrids as the potential anticancer agents: an overview","volume":"205","author":"Liu","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0110","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4314\/tjpr.v19i5.7","article-title":"Cinnamic hydroxamic acid inhibits the proliferation of gastric cancer cells via upregulation of miR 145 expression and down-regulation of P13K\/Akt signaling pathway","volume":"19","author":"Li","year":"2020","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.bmc.2025.118396_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115879","article-title":"Hydroxamic acid hybrids: histone deacetylase inhibitors with anticancer therapeutic potency","volume":"262","author":"Pan","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0120","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1016\/j.ejmech.2011.08.045","article-title":"Design, synthesis and primary activity assay of tripeptidomimetics as histone deacetylase inhibitors with linear linker and branched cap group","volume":"46","author":"Zhang","year":"2011","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107968","article-title":"Design, synthesis, and antiproliferative activity evaluation of novel alpha-mangostin derivatives by ROS\/MAPK signaling pathway","volume":"153","author":"Fredimoses","year":"2024","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0130","doi-asserted-by":"crossref","first-page":"9179","DOI":"10.1021\/acs.joc.9b01128","article-title":"Regio- and Diastereoselective access to 4-Imidazolidinones via an Aza-Mannich initiated cyclization of Sulfamate-derived cyclic imines with alpha-halo Hydroxamates","volume":"84","author":"Zhou","year":"2019","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0135","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1021\/acs.jmedchem.1c02225","article-title":"Discovery of DNA-targeting HDAC inhibitors with potent antitumor efficacy in vivo that trigger antitumor immunity","volume":"65","author":"Chen","year":"2022","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106328","article-title":"The dual FAK-HDAC inhibitor MY-1259 displays potent activities in gastric cancers in vitro and in vivo","volume":"131","author":"Song","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2025.118396_bb0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40164-024-00507-5","article-title":"Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives","volume":"13","author":"Pu","year":"2024","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.bmc.2025.118396_bb0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/med.21320","article-title":"Trend of histone deacetylase inhibitors in cancer therapy: isoform selectivity or multitargeted strategy","volume":"35","author":"Zhang","year":"2015","journal-title":"Med Res Rev"},{"key":"10.1016\/j.bmc.2025.118396_bb0155","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.biopha.2016.10.057","article-title":"Panobinostat induces apoptosis via production of reactive oxygen species and synergizes with topoisomerase inhibitors in cervical cancer cells","volume":"84","author":"Wasim","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.bmc.2025.118396_bb0160","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089625003372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:34:04Z","timestamp":1780403644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089625003372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":32,"alternative-id":["S0968089625003372"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118396","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of hydroxamate derivatives as potent anti-gastric cancer agents via inducing oxidative stress and DNA damage","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2025.118396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118396"}}